000			02332 a2200613 4500
005			20250515085747.0
264		0	_c20071018
008			200710s 0 0 eng d
022			_a0004-0010
024	7		_a10.1001/archsurg.142.9.855 _2doi
040			_aNLM _beng _cNLM
100	1		_aHsiang, David J
245	0	0	_aPredicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab. _h[electronic resource]
260			_bArchives of surgery (Chicago, Ill. : 1960) _cSep 2007
300			_a855-61; discussion 860-1 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aAxilla
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCarboplatin _xadministration & dosage
650	0	4	_aContrast Media
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aGadolinium DTPA
650	0	4	_aHumans
650	0	4	_aLymph Node Excision
650	0	4	_aLymph Nodes _xpathology
650	0	4	_aLymphatic Metastasis
650	0	4	_aMagnetic Resonance Imaging _xmethods
650	0	4	_aMastectomy
650	0	4	_aMastectomy, Segmental
650	0	4	_aMiddle Aged
650	0	4	_aNeoadjuvant Therapy
650	0	4	_aPaclitaxel _xadministration & dosage
650	0	4	_aPredictive Value of Tests
650	0	4	_aReceptor, ErbB-2 _xanalysis
650	0	4	_aRetrospective Studies
650	0	4	_aSensitivity and Specificity
650	0	4	_aTrastuzumab
650	0	4	_aTreatment Outcome
700	1		_aYamamoto, Maki
700	1		_aMehta, Rita S
700	1		_aSu, Min-Ying
700	1		_aBaick, Choong H
700	1		_aLane, Karen T
700	1		_aButler, John A
773	0		_tArchives of surgery (Chicago, Ill. : 1960) _gvol. 142 _gno. 9 _gp. 855-61; discussion 860-1
856	4	0	_uhttps://doi.org/10.1001/archsurg.142.9.855 _zAvailable from publisher's website
999			_c17400655 _d17400655